Warner Biddle
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Warner Biddle currently works at Kyverna Therapeutics, Inc., as Chief Executive Officer & Director from 2024.
Mr. Biddle also formerly worked at Genentech, Inc., as Vice President-Sales & Marketing and Kite Pharma, Inc., as Senior Vice President & Global Head-Commercial.
Mr. Biddle received his undergraduate degree from the University of Saskatchewan.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Vorstandsvorsitzender | 16.09.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Vertrieb & Marketing | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of Saskatchewan
University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen